Using positron emission tomography 2-deoxy-2-[18F]fluoro-D-glucose, 11CO, and 15O-water for monitoring androgen independent prostate cancer.

Molecular imaging and biology : MIB : the official publication of the Academy of Molecular Imaging

Volumn 5, Issue 2, 2003, Pages 86-93

  Kurdziel, Karen A ^a   Figg, William D ^a   Carrasquillo, Jorge A ^a   Huebsch, Susan ^a   Whatley, Millie ^a   Sellers, David ^a   Libutti, Steven K ^a   Pluda, James M ^a   Dahut, William ^a   Reed, Edward ^a   Bacharach, Stephen L ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN; ANTINEOPLASTIC AGENT; CARBON; CARBON MONOXIDE; DIAGNOSTIC AGENT; FLUORODEOXYGLUCOSE F 18; GLUCOSE; OXYGEN; RADIOPHARMACEUTICAL AGENT; THALIDOMIDE; WATER;

AGED; ARTICLE; CLINICAL TRIAL; COMPUTER ASSISTED EMISSION TOMOGRAPHY; HUMAN; MALE; METABOLISM; METHODOLOGY; MIDDLE AGED; PHASE 2 CLINICAL TRIAL; PHYSIOLOGY; PROSTATE TUMOR; SCINTISCANNING;

AGED; ANDROGENS; ANTINEOPLASTIC AGENTS; CARBON MONOXIDE; CARBON RADIOISOTOPES; FLUORODEOXYGLUCOSE F18; GLUCOSE; HUMANS; MALE; MIDDLE AGED; OXYGEN RADIOISOTOPES; PROSTATIC NEOPLASMS; RADIOPHARMACEUTICALS; THALIDOMIDE; TOMOGRAPHY, EMISSION-COMPUTED; WATER;

EID: 5444229812     PISSN: 15361632     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1536-1632(03)00039-8     Document Type: Article

References (0)